Can industrial carve-outs still create alpha in a higher-rate, lower-multiple environment?

The era of cheap debt, frothy multiples, and easy exits may be behind us. But the industrial carve-out playbook is far from obsolete. Even in today’s higher-rate, lower-valuation landscape, private equity firms like Carlyle are doubling down on complex carve-outs in manufacturing, chemicals, and specialty industrials—betting that operational muscle, patient capital, and strategic realignment can still generate above-market returns.

The recent €7.7 billion deal between BASF SE and Carlyle Group for BASF’s coatings business is a case in point. The deal, which includes minority co-investment from Qatar Investment Authority and retains BASF’s 40% stake, is more than a standalone transaction. It’s a signal that private equity appetite for industrial carve-outs remains strong, despite a radically different macro backdrop than in the previous decade.

In a world where valuations have compressed and debt comes with tighter terms, can the classic alpha narrative of carve-outs still hold? Or is the model overdue for reinvention?

Why are industrial carve-outs gaining traction despite high interest rates and valuation headwinds?

Even amid macroeconomic tightening, carve-outs are quietly resurging as corporates accelerate efforts to shed non-core units and focus on streamlined capital allocation. Private equity firms, for their part, are eager buyers—not just of assets, but of complexity. They are hunting for structurally inefficient business units where operational improvement, commercial discipline, and sharper focus can drive returns that pure multiple arbitrage no longer delivers.

In the first half of 2025, carve-out deal volume in global private equity rose notably, driven by multinationals seeking simplification, resilience, and capital for reinvestment. Across sectors such as chemicals, industrial automation, and auto components, large conglomerates are offloading units that no longer fit their growth story. Buyers like Carlyle, Advent, SK Capital, and Platinum Equity are stepping in with aggressive carve-out strategies, bringing transition expertise, capital, and the patience to unlock long-term value.

These are not quick flips or low-risk bolt-ons. Carve-outs in today’s climate require balance-sheet rigor, operational tenacity, and clear value-creation pathways. The backdrop of elevated rates and compressed valuations means that buyers must look beyond headline metrics and underwrite real transformation from day one.

How is the definition of alpha changing for carve-outs in the post-leverage era?

In previous cycles, private equity sponsors often relied heavily on leverage and valuation expansion to meet their IRR targets. The typical formula—buy at 9× EBITDA, exit at 12×—left room for generous returns even if operational performance lagged. But as interest rates remain elevated and valuation multiples reset across sectors, that formula no longer guarantees alpha.

Today, value creation has shifted from financial engineering to operational execution. Private equity firms are now focusing more intensively on standalone margin improvement, supply chain localization, working capital optimization, and growth from pricing power and commercial discipline. The deals that win are those that can stand up a business quickly, scale efficiently, and build capabilities that justify premium multiples on exit.

Operational playbooks have evolved too. Transition service agreements, once treated as afterthoughts, are now central to deal modeling. Carve-out buyers are stress-testing working capital assumptions, systems disentanglement costs, and stranded cost burdens before ever signing a term sheet. Margin expansion has to be real and quantifiable—not just theoretical.

Carve-outs today are not about leverage expansion. They are about executing fast, absorbing transitional pain early, and positioning the business for organic growth and bolt-on scale-ups that can shift the valuation curve.

What are the biggest execution risks in industrial carve-outs right now?

The complexity of carving out a business from a global industrial giant is immense. And in today’s environment, those risks are magnified.

One of the largest challenges lies in disentangling shared services. Carved-out divisions often rely on their parent company’s IT systems, HR processes, procurement functions, and compliance infrastructure. Creating a clean break without disrupting operations is a resource-intensive, high-stakes exercise. Underestimating the true cost of that separation—both financial and organizational—can derail early performance and strain cash flow.

Leadership gaps are another key concern. Often, the most experienced managers remain with the parent company. Sponsors must quickly install executive teams capable of navigating not just standalone operations, but also culture change and strategic pivoting. These teams must align quickly with PE playbooks while retaining customer continuity and internal cohesion.

Cost overruns are also common. Stand-up costs, one-time legal or compliance fees, and delayed TSA exits can eat into year-one EBITDA and threaten early covenant compliance. Moreover, regulatory fragmentation across regions can turn what looks like a single carve-out into a patchwork of jurisdictional issues, licensing delays, and supply chain renegotiations.

Finally, macro shocks—commodity price volatility, currency swings, or geopolitical disruptions—can wreak havoc on carved-out units that no longer have the cushion of a larger parent balance sheet. Risk mitigation must be embedded into every layer of the transition strategy.

Where have carve-outs succeeded—and what can we learn from those examples?

While the risks are real, there are several high-profile carve-outs that have delivered strong returns even amid uncertain cycles.

Carlyle’s earlier spinout of Axalta from DuPont remains one of the most cited success stories. The coatings business, once a neglected corporate orphan, became a focused, margin-rich public company. Similar stories emerged from Atotech (spun out of Total SA) and Nouryon (from AkzoNobel), where operational independence led to strong private equity exits.

These successes share common features. First, the buyers had a detailed transition plan that de-risked the Day One operating model. Second, they invested early in commercial capability, cost discipline, and standalone infrastructure. Third, they avoided the temptation to slash costs indiscriminately, instead focusing on value creation through targeted initiatives—such as SKU optimization, pricing analytics, or digital manufacturing.

Importantly, these deals succeeded not because of financial leverage, but because of execution excellence and sector familiarity. They also benefited from timing their exits during more favorable multiple environments, a luxury that today’s buyers may not always enjoy.

How are valuation and financing dynamics reshaping private equity carve-out models?

The math has changed. Multiples have compressed across industrials and chemicals, with public comps resetting lower and private buyers exercising greater discipline. Where 12× EV/EBITDA was once the norm for specialty units, many are now trading at 9–10× or less.

On the financing side, lenders are more selective. Credit spreads remain elevated, and covenant structures are tighter. Sponsors can no longer rely on 6–7× leverage packages to juice returns. Many deals are now structured with 3.5–5× debt multiples and larger equity cushions, meaning more pressure on operational performance to hit return hurdles.

All of this means that internal IRR targets must increasingly come from genuine margin expansion, not paper gains. And with exit timing more uncertain in a volatile macro, sponsors are building in longer hold periods, more flexible exit options, and in some cases, exploring dual-track IPOs earlier.

Investors and LPs are watching closely to see if this new breed of carve-out can deliver returns consistent with prior vintages—and whether GPs have truly adjusted their playbooks to match a higher-risk, lower-reward reality.

What should investors and stakeholders watch in the next wave of carve-outs?

As more carve-outs hit the market, investors, LPs, and co-investors will be scrutinizing a new set of performance signals. These include the speed at which TSAs are unwound, the sustainability of early-year EBITDA margins, the quality of new leadership teams, and the ability to execute bolt-on acquisitions without derailing integration.

Standalone revenue growth will be a key benchmark, particularly in sectors like chemicals and coatings where volume volatility can mask true pricing power. Cash conversion, not just adjusted EBITDA, will become a primary metric of carve-out health.

The BASF–Carlyle coatings deal will be a closely watched bellwether. If Carlyle can stabilize the business, drive commercial focus, and pursue strategic M&A within 24 months, it will reinforce the narrative that industrial carve-outs remain a source of alpha—even in a world where leverage is no longer the star of the show.

Ultimately, the future of carve-outs will depend not on what they cost—but on what sponsors do with them once they’re cut free.